Veronica Laboratories Ltd. - Research Center
524802 VEROLAB Group (XD) BSE data
Results
Statement
More
Mar ' 04 |
Mar ' 03 |
Mar ' 02 |
Mar ' 01 |
Mar ' 00 |
Equity share capital
10.02 |
10.01 |
9.80 |
9.80 |
9.80 |
Share application money
Preference share capital
Reserves & surplus
Secured loans
Unsecured loans
Total
12.70 |
12.68 |
17.99 |
17.78 |
17.15 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
13.59 |
11.60 |
11.62 |
12.06 |
10.46 |
Less : current liabilities & provisions
Total net current assets
9.84 |
9.33 |
11.18 |
11.06 |
9.52 |
Miscellaneous expenses not written
Total
12.70 |
12.68 |
17.99 |
17.78 |
17.15 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
100.20 |
100.25 |
98.14 |
98.14 |
98.14 |